| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia
|
Piard, Christine
|
|
2006
|
60 |
4 |
p. 609-620
|
artikel
|
| 2 |
A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia
|
Piard, Christine
|
|
|
60 |
4 |
p. 609-620
|
artikel
|
| 3 |
A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia
|
Plard, Christine
|
|
2007
|
60 |
4 |
p. 621
|
artikel
|
| 4 |
A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma
|
Park, Byeong-Bae
|
|
|
60 |
4 |
p. 489-494
|
artikel
|
| 5 |
A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma
|
Park, Byeong-Bae
|
|
2007
|
60 |
4 |
p. 489-494
|
artikel
|
| 6 |
A phase I pharmacodynamic study of the effects of the cyclin-dependent kinase-inhibitor AZD5438 on cell cycle markers within the buccal mucosa, plucked scalp hairs and peripheral blood mononucleocytes of healthy male volunteers
|
Camidge, D. Ross
|
|
|
60 |
4 |
p. 479-488
|
artikel
|
| 7 |
A phase I pharmacodynamic study of the effects of the cyclin-dependent kinase-inhibitor AZD5438 on cell cycle markers within the buccal mucosa, plucked scalp hairs and peripheral blood mononucleocytes of healthy male volunteers
|
Camidge, D. Ross
|
|
2006
|
60 |
4 |
p. 479-488
|
artikel
|
| 8 |
DPYD*2A mutation: the most common mutation associated with DPD deficiency
|
Saif, M. W.
|
|
2006
|
60 |
4 |
p. 503-507
|
artikel
|
| 9 |
Effect of a V-ATPase inhibitor, FR202126, in syngeneic mouse model of experimental bone metastasis
|
Niikura, Kazuaki
|
|
|
60 |
4 |
p. 555-562
|
artikel
|
| 10 |
Effect of a V-ATPase inhibitor, FR202126, in syngeneic mouse model of experimental bone metastasis
|
Niikura, Kazuaki
|
|
2006
|
60 |
4 |
p. 555-562
|
artikel
|
| 11 |
Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer
|
Fujita, Ken-ichi
|
|
|
60 |
4 |
p. 515-522
|
artikel
|
| 12 |
Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer
|
Fujita, Ken-ichi
|
|
2007
|
60 |
4 |
p. 515-522
|
artikel
|
| 13 |
Influence of ketoconazole on the fecal and urinary disposition of docetaxel
|
Engels, Frederike K.
|
|
2007
|
60 |
4 |
p. 569-579
|
artikel
|
| 14 |
Is rectal administration an alternative route for imatinib?
|
Erp, Nielka P. H. van
|
|
2007
|
60 |
4 |
p. 623-624
|
artikel
|
| 15 |
Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in mice
|
Bruynzeel, Anna M. E.
|
|
|
60 |
4 |
p. 509-514
|
artikel
|
| 16 |
Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in mice
|
Bruynzeel, Anna M. E.
|
|
2006
|
60 |
4 |
p. 509-514
|
artikel
|
| 17 |
Pharmacology of intracellular cytosine-arabinoside-5′-triphosphate in malignant cells of pediatric patients with initial or relapsed leukemia and in normal lymphocytes
|
Koehl, U.
|
|
|
60 |
4 |
p. 467-477
|
artikel
|
| 18 |
Pharmacology of intracellular cytosine-arabinoside-5′-triphosphate in malignant cells of pediatric patients with initial or relapsed leukemia and in normal lymphocytes
|
Koehl, U.
|
|
2006
|
60 |
4 |
p. 467-477
|
artikel
|
| 19 |
Phase I and pharmacokinetic trial of AP5346, a DACH–platinum–polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients
|
Campone, Mario
|
|
|
60 |
4 |
p. 523-533
|
artikel
|
| 20 |
Phase I and pharmacokinetic trial of AP5346, a DACH–platinum–polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients
|
Campone, Mario
|
|
2007
|
60 |
4 |
p. 523-533
|
artikel
|
| 21 |
Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
|
Wang, Lin Run
|
|
2007
|
60 |
4 |
p. 601-607
|
artikel
|
| 22 |
Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer
|
Kawamura, Masafumi
|
|
|
60 |
4 |
p. 495-501
|
artikel
|
| 23 |
Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer
|
Kawamura, Masafumi
|
|
2006
|
60 |
4 |
p. 495-501
|
artikel
|
| 24 |
Plasma and cerebrospinal fluid pharmacokinetics of intravenously administered ABT-751 in non-human primates
|
Cho, Steve Y.
|
|
2006
|
60 |
4 |
p. 563-567
|
artikel
|
| 25 |
Preclinical antitumor activity of the oral platinum analog satraplatin
|
Wosikowski, Katja
|
|
|
60 |
4 |
p. 589-600
|
artikel
|
| 26 |
Preclinical antitumor activity of the oral platinum analog satraplatin
|
Wosikowski, Katja
|
|
2007
|
60 |
4 |
p. 589-600
|
artikel
|
| 27 |
R-etodolac (SDX-101) and the related indole–pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells
|
Lindhagen, Elin
|
|
2006
|
60 |
4 |
p. 545-553
|
artikel
|
| 28 |
Targeting c-Src kinase enhances tamoxifen’s inhibitory effect on cell growth by modulating expression of cell cycle and survival proteins
|
Planas-Silva, Maricarmen D.
|
|
2006
|
60 |
4 |
p. 535-543
|
artikel
|
| 29 |
Targeting c-Src kinase enhances tamoxifen’s inhibitory effect on cell growth by modulating expression of cell cycle and survival proteins
|
Planas-Silva, Maricarmen D.
|
|
|
60 |
4 |
p. 535-543
|
artikel
|
| 30 |
Trichosanthin down-regulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562
|
Zhang, Kunzhong
|
|
2007
|
60 |
4 |
p. 581-587
|
artikel
|
| 31 |
Trichosanthin down-regulated p210Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562
|
Zhang, Kunzhong
|
|
|
60 |
4 |
p. 581-587
|
artikel
|
Tijdschrift beschrijving